Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Karnataka Bank partners with HDFC Life, shares in focus after rally
Post Content Post Views: 53
US FAA tightens aircraft certification oversight after Boeing MAX crashes
Post Content Post Views: 49
Charlie Munger, investing genius and Warren Buffett’s right-hand man, dies at age 99
“We think so much alike that it’s spooky,” Warren Buffett once said of Munger. Post Views: 60
Gold prices rally before Fed minutes, copper rises on tighter supplies
Post Content Post Views: 71
BMO Mid Corporate Bond Index ETF declares CAD 0.05 dividend
Post Content Post Views: 57
Gen Z, millennials are ‘house hacking’ to become homeowners. How the strategy can help
Gen Zers and millennials are using “house hacking” as a way to secure homeownership in a tough market. Here’s how the strategy works. Post Views: 52